Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Loxo Oncology, Inc. | 3,438,920 | reported | 19 Dec 2017 | tx 5+576,227−250,000 |
| T2 Biosystems, Inc. | 2,830,992 | reported | 09 Dec 2015 | tx 1+307,692 |
| AGILE THERAPEUTICS INC | 2,583,797 | reported | 02 Jun 2016 | tx 1−400,000 |
| Durata Therapeutics, Inc. | 2,019,713 | reported | 24 Jul 2012 | tx 3+3,130,824−16,157,707 |
| Syros Pharmaceuticals, Inc. | 508,565 | reported | 06 Jul 2016 | tx 3+908,565−1,907,122 |
| Zeltiq Aesthetics Inc | 4,697 | reported | 23 Jan 2014 | tx 5+8,247−999,020 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Dec 2017 | SALE | Loxo Oncology, Inc. | 250,000 | 80.50 USD | |
| 06 Jul 2016 | PURCHASE | Syros Pharmaceuticals, Inc. | 400,000 | 12.50 USD | |
| 06 Jul 2016 | CONVERSION | Syros Pharmaceuticals, Inc. | 508,565 | — | |
| 06 Jul 2016 | CONVERSION | Syros Pharmaceuticals, Inc. | 1,907,122 | 0.00 USD | deriv |
| 02 Jun 2016 | OTHER | AGILE THERAPEUTICS INC | 400,000 | 0.00 USD | |
| 17 May 2016 | PURCHASE | Loxo Oncology, Inc. | 232,558 | 21.50 USD | |
| 09 Dec 2015 | PURCHASE | T2 Biosystems, Inc. | 307,692 | 9.75 USD | |
| 17 Nov 2015 | PURCHASE | Loxo Oncology, Inc. | 265,000 | 26.50 USD | |
| 12 Nov 2015 | PURCHASE | Loxo Oncology, Inc. | 76,714 | 27.65 USD | first after silence |
| 13 Nov 2015 | PURCHASE | Loxo Oncology, Inc. | 1,955 | 27.47 USD | |
| 23 Jan 2014 | OTHER | Zeltiq Aesthetics Inc | 1,152 | 0.00 USD | |
| 23 Jan 2014 | OTHER | Zeltiq Aesthetics Inc | 2,398 | 0.00 USD | |
| 23 Jan 2014 | OTHER | Zeltiq Aesthetics Inc | 4,697 | 0.00 USD | |
| 23 Jan 2014 | OTHER | Zeltiq Aesthetics Inc | 994,305 | 0.00 USD | |
| 23 Jan 2014 | OTHER | Zeltiq Aesthetics Inc | 4,715 | 0.00 USD | |
| 24 Jul 2012 | CONVERSION | Durata Therapeutics, Inc. | 2,019,713 | 0.00 USD | |
| 24 Jul 2012 | PURCHASE | Durata Therapeutics, Inc. | 1,111,111 | 9.00 USD | |
| 24 Jul 2012 | CONVERSION | Durata Therapeutics, Inc. | 16,157,707 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 12 Nov 2015.